Last updated: March 6, 2024
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Overall Status: Active - Recruiting
Phase
N/A
Condition
Uterine Disorders
Treatment
Hysterotomy closure
Clinical Study ID
NCT06308172
CSI/2021
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- nulliparous
- singleton
- age 18-45
- spontaneous pregnancy or autologous assisted fertilization
- gestational age 38-40 weeks
- elective C-section
- informed consent
Exclusion
Exclusion Criteria:
- coagulopathy
- autoimmune diseases
- gestational diabetes
- anticoagulant therapy
- immunosuppressive therapy
- endometriosis
- uterine fibromatosis
- spontaneous labour
- connective tissue diseases
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Hysterotomy closure
Phase:
Study Start date:
December 01, 2021
Estimated Completion Date:
December 01, 2026
Study Description
Connect with a study center
Fondazione Cà Granda IRCCS Ospedale Maggiore Policlinico di Milano
Milan, Mi 20122
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.